Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II

Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II

US Patent 10179816 · Granted Jan 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of ADCC-optimized antibodies for treating low-responder patients2018
Antibody method for treatment of a disease in which the target cells are cells w2018
Mutated humanized 12G4 antibodies and the fragments thereof against the human an2017
Pharmaceutical compositions comprising an antibody which binds the human anti-mu2016
Pharmaceutical compositions comprising an antibody which binds the human anti-mu2016
Monoclonal antibody directed against CD20 antigen2016
Use of ADCC-optimized antibodies for treating weak patients2015
Mutated humanized 12G4 antibodies and the fragments thereof against the human an2015
Use of ADCC-optimized antibodies for treating weak patients2013
Anti-rhesus D monoclonal antibody2013
Cytotoxic antibodies directed against antibodies inhibiting factor VIII2011
Use of ADCC-optimized antibodies for treating low-responder patients2010